trending Market Intelligence /marketintelligence/en/news-insights/trending/v05Gvr25JNrTl8xuT7Uy4g2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Impulse Dynamics device to treat heart failure gains US FDA approval

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Impulse Dynamics device to treat heart failure gains US FDA approval

The U.S. Food and Drug Administration has granted approval to Impulse Dynamics NV's Optimizer Smart system to treat patients with chronic, moderate-to-severe heart failure who cannot use other devices.

According to the U.S. regulator, about 5.7 million people in the U.S. have heart failure, a condition in which the heart fails to pump enough blood to meet the body's need.

Optimizer Smart system uses a pulse generator implanted under the skin to deliver electrical impulses to the heart that improve its blood pumping capacity.

FDA's approval is based on results from two clinical trials with 389 patients with moderate to severe heart failures, where 191 received Optimizer Smart system implants. Results from the trials indicated improvements in distance covered during six-minute walking tests by patients with the implant along with improvements on assessments to measure heart failure symptoms.

The U.S. FDA had previously granted Optimizer Smart system a breakthrough device designation. Under the designation, the FDA provided intensive interaction and guidance to the company on efficient device development, to expedite evidence generation and the agency's review of the device.